Innovators seeking to develop and commercialize new clinical products face a complex landscape of regulatory requirements, market access, and competitive challenges. There is a critical need for strategic insights to guide informed decision-making from early asset evaluation to commercialization.

By integrating clinical, medical, regulatory, and commercial expertise, our experts help biotech and pharma companies’ make informed investment decisions and maximize program potential at every stage.

Whether you’re assessing KOL and payor research or positioning your innovation for business development and licensing, Premier’s data-driven approach ensures you stay ahead in a competitive market. We’ll work with you to deliver a comprehensive range of services tailored to your current development needs.

Commercial Assessments and Competitive Landscape Analysis

This broad strategic overview summarizes the potential markets and opportunities to position a product or portfolio for the greatest success. Tailored for your individual needs, recommendations typically inform early development priorities or “go/no go” decisions for later stage assets based on the following analyses:

• Unmet Medical Needs
• Patient & Provider Treatment Journey
• Standard of Care
• Current & Future Competitive Landscape
• Payor & Reimbursement Landscape
• Target Patient Population
• Target Product Profile
• Focused KOL & HCP Research
• Market Sizing and Framing
• Valuation, Assumptions and Sensitivities

Competitive Value Optimization

Completing this strategic engagement will confirm drivers of market access, define product, and enable the optimization of potential value differentiators vs. future competition. Output informs key development decisions, product positioning, and requirements for out-licensing or commercialization. Our analysis will typically include:

• Focused KOL Research
• Payor Market Research
• Competitor Value Proposition Definition
• Analyses and Scenario Planning
• Product Positioning Strategy

Platform, Portfolio, and Indication Prioritization

Our strategic assessment integrates market access and new product strategy with medical, clinical, and regulatory considerations to evaluate and prioritize development. Our deep bench of development consultants, regulatory strategists, and clinical experts offer insights and strategy recommendations to define risk and guide investment and resourcing.

Product Screen and Evaluation

Objective insights regarding product feasibility and market value are necessary to enhance corporate decision-making as you assess product potential and valuation. Through targeted engagements, we support corporate business development with the product screen and evaluation process, serving as an extension of the sponsor team or acting as an independent third party.

Build Your Strategy to Conquer the Market

Contact Premier today to discuss ways to optimize your new product development plan and explore market-entry strategies.